BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8831765)

  • 1. Homology modeling of metabotropic glutamate receptors. (mGluRs) structural motifs affecting binding modes and pharmacological profile of mGluR1 agonists and competitive antagonists.
    Costantino G; Pellicciari R
    J Med Chem; 1996 Sep; 39(20):3998-4006. PubMed ID: 8831765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orthosteric and allosteric drug binding sites in the Caenorhabditis elegans mgl-2 metabotropic glutamate receptor.
    Tharmalingam S; Burns AR; Roy PJ; Hampson DR
    Neuropharmacology; 2012 Sep; 63(4):667-74. PubMed ID: 22652059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding.
    Litschig S; Gasparini F; Rueegg D; Stoehr N; Flor PJ; Vranesic I; Prézeau L; Pin JP; Thomsen C; Kuhn R
    Mol Pharmacol; 1999 Mar; 55(3):453-61. PubMed ID: 10051528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioligand binding properties and pharmacological characterization of 6-amino-N-cyclohexyl-N,3-dimethylthiazolo[3,2-a]benzimidazole-2-carboxamide (YM-298198), a high-affinity, selective, and noncompetitive antagonist of metabotropic glutamate receptor type 1.
    Kohara A; Toya T; Tamura S; Watabiki T; Nagakura Y; Shitaka Y; Hayashibe S; Kawabata S; Okada M
    J Pharmacol Exp Ther; 2005 Oct; 315(1):163-9. PubMed ID: 15976016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2.
    Schaffhauser H; Rowe BA; Morales S; Chavez-Noriega LE; Yin R; Jachec C; Rao SP; Bain G; Pinkerton AB; Vernier JM; Bristow LJ; Varney MA; Daggett LP
    Mol Pharmacol; 2003 Oct; 64(4):798-810. PubMed ID: 14500736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist selectivity of mGluR1 and mGluR2 metabotropic receptors: a different environment but similar recognition of an extended glutamate conformation.
    Jullian N; Brabet I; Pin JP; Acher FC
    J Med Chem; 1999 May; 42(9):1546-55. PubMed ID: 10229625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants of ligand discrimination in the glutamate-binding pocket of the NMDA receptor.
    Laube B; Schemm R; Betz H
    Neuropharmacology; 2004 Dec; 47(7):994-1007. PubMed ID: 15555634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel transmembrane domain involved in the negative modulation of mGluR1 using a newly discovered allosteric mGluR1 antagonist, 3-cyclohexyl-5-fluoro-6-methyl-7-(2-morpholin-4-ylethoxy)-4H-chromen-4-one.
    Fukuda J; Suzuki G; Kimura T; Nagatomi Y; Ito S; Kawamoto H; Ozaki S; Ohta H
    Neuropharmacology; 2009 Sep; 57(4):438-45. PubMed ID: 19559036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) acts through a novel site as a positive allosteric modulator of group 1 metabotropic glutamate receptors.
    Chen Y; Goudet C; Pin JP; Conn PJ
    Mol Pharmacol; 2008 Mar; 73(3):909-18. PubMed ID: 18056795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist.
    Moroni F; Lombardi G; Thomsen C; Leonardi P; Attucci S; Peruginelli F; Torregrossa SA; Pellegrini-Giampietro DE; Luneia R; Pellicciari R
    J Pharmacol Exp Ther; 1997 May; 281(2):721-9. PubMed ID: 9152378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
    Moretti L; Pentikäinen OT; Settimo L; Johnson MS
    J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
    Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
    Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of striatal metabotropic glutamate receptors in Parkinson's disease.
    Ossowska K; Konieczny J; Wardas J; Gołembiowska K; Wolfarth S; Pilc A
    Amino Acids; 2002; 23(1-3):193-8. PubMed ID: 12373537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine.
    Malherbe P; Kratochwil N; Zenner MT; Piussi J; Diener C; Kratzeisen C; Fischer C; Porter RH
    Mol Pharmacol; 2003 Oct; 64(4):823-32. PubMed ID: 14500738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabotropic glutamate receptor/phospholipase C system in female rat heart.
    Iglesias I; Castillo CA; León D; Ruíz MA; Albasanz JL; Martín M
    Brain Res; 2007 Jun; 1153():1-11. PubMed ID: 17493590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of amino-terminal domains of group I metabotropic glutamate receptors: structural motifs affecting ligand selectivity.
    Costantino G; Macchiarulo A; Pellicciari R
    J Med Chem; 1999 Dec; 42(26):5390-401. PubMed ID: 10639281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model for a glutamate receptor agonist antibody-binding site.
    McDonald S; Carlson NG; Gahring LC; Ely KR; Rogers SW
    J Mol Recognit; 1999; 12(4):219-25. PubMed ID: 10440992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of neuronal network excitability and seizure-like events by 2-methyl-4-oxo-3H-quinazoline-3-acetyl piperidine in juvenile rat hippocampus: involvement of a metabotropic glutamate receptor.
    Lasztóczi B; Emri Z; Szárics E; Héja L; Simon A; Nyikos L; Kardos J
    Neurochem Int; 2006 Jul; 49(1):41-54. PubMed ID: 16490284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
    Axe FU; Bembenek SD; Szalma S
    J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology model of the closed, functionally active, form of the amino terminal domain of mGlur1.
    Costantino G; Macchiarulo A; Pellicciari R
    Bioorg Med Chem; 2001 Apr; 9(4):847-52. PubMed ID: 11354667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.